ShouTi Company
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Investors
Founded Date:
2016-01-01
Funding Status:
Early Stage Venture
Total Funding:
207000000.0
Employee Number:
11-50
Headquarters:
South San Francisco, California, United States
Last Funding Date:
2021-10-20
Investors Number:
18.0
Last Funding Type:
Series B
Industry:
Early Drug Development